BioTek customer statement on COVID-19 coronavirus

April 1, 2020

At BioTek, now a part of Agilent, supporting our customers is a key priority. Our global teams are hard at work to avoid disruptions from the COVID-19 virus while at the same time acting responsibly to do what we can to prevent further spread. We have put measures and precautions in place to keep our customers and employees safe while continuing to serve the scientific community. Our sales and service teams are actively assisting customers remotely using virtual tools and technologies to minimize in person visits. We know BioTek’s customer support is something you value and is essential to your research. We are committed to supporting you in any capacity we can, safely. In addition, our manufacturing facility is operating at normal capacity and we continue to innovate and develop new products.

We would like to thank all of you who are diligently working on the front lines as we, a global community, fight this virus and search for a cure and vaccine. We are here to help you in whatever way we can.  If your lab is doing COVID-19 diagnostic testing, BioTek offers several solutions that accelerate the processing of thousands of samples, including bulk dispense of PCR master mix. Contact us to discuss whether these solutions can aid in your research and know that budgetary or shipping concerns can be mitigated during this important time. We will do everything possible to meet your needs and expedite high-need shipments.

We continue to closely monitor and assess the evolving situation and will be diligent about communicating with affected customers regarding shipment timing or other issues resulting from this situation.

For a complete and up-to-date statement from Agilent, click here.